Service & contributions

Reports, entreaties & committees

Policy reports, governance documents, standards committees, and workshops Yonatan has contributed to — alongside the research papers and patents listed elsewhere.

Policy reports & white papers

Public-facing documents shaping how engineered biology gets regulated, deployed, and governed.

2026 Contributor

A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States

OECD Science, Technology and Industry Working Papers No. 2026/02 · Barraza-Botet et al. · January 2026

OECD working paper comparing innovation-enabling conditions and regulatory practices for biotechnology and biosolutions across the EU and the U.S. — covering venture capital, patenting, workforce, manufacturing capacity, and shared regulatory challenges (uncertainty, fragmentation, complexity, lengthy approvals). Supports transatlantic policymakers in designing frameworks that foster innovation while managing risk.

2026 Expert review panelist

Supporting Responsible Innovation of Synthetic Cells

National Academies of Sciences, Engineering, and Medicine · Board on Life Sciences · April 2026

NAS consensus report on the biosafety, biosecurity, and environmental considerations of synthetic cell research and development — outlining a national strategy for responsible innovation in the field. Yonatan served as an expert review panelist for the project ("External Review of Environmental, Biosafety, and Biosecurity Considerations for Synthetic Cell Research and Development," DELS-BLS-22-12).

2026 First author

Responsible biotechnology: an analysis of the Asilomar 2025 entreaties

Y. Chemla & C. A. Voigt · Trends in Biotechnology · Feature Review · 2026

A Feature Review synthesizing the 27 Spirit of Asilomar 2025 entreaties into concrete action items — spanning the environmental release of engineered organisms, biosecurity, AI in the biosciences, education, governance, and regulation — and contextualizing them within the broader literature fifty years after the original Asilomar meeting. (Distills the entreaties into reform calls including product-not-process regulation, evidence-based adaptive risk assessment, and infrastructure for transparent field release.)

2025 First author

Design and regulation of engineered bacteria for environmental release

Y. Chemla, C. J. Sweeney, C. A. Wozniak, C. A. Voigt · Nature Microbiology · 2025

A review consolidating the scientific and regulatory landscape for engineered bacteria in the open environment — covering the U.S. Coordinated Framework, EPA/USDA/FDA jurisdictions, and the design choices labs must make to release safely. Widely cited as a reference for the next-generation EMER regulatory conversation.

2024 Workshop participant

Policy Recommendations for the Regulation of Engineered Microbes for Environmental Release (EMER Report)

Caltech Linde Center for Science, Society and Policy (LCSSP) · Marken, Maxon & Murray (eds.) · June 2024

A landmark policy report developing recommendations for how the U.S. should regulate Engineered Microbes for Environmental Release. Authored by LCSSP following the "Pathways Towards the Safe and Effective Deployment of Engineered Microbial Technologies" workshop (Caltech, Feb 2024), in which Yonatan was a workshop participant alongside Voigt, Murray, Maxon, EPA, USDA, ZBiotics, Pivot Bio, Corteva, and others.

Spirit of Asilomar 2025 entreaties

In 2025, on the 50th anniversary of the original Asilomar Conference on recombinant DNA, the “Spirit of Asilomar and the Future of Biotechnology” summit (Pacific Grove, CA, Feb 23–26) produced 27 entreaties on the governance of modern biotechnology. Yonatan authored one and co-authored two more.

2025 First author

Identifying and Addressing the Risk of the Environmental Release of Organisms — Engineered or Natural

Y. Chemla, T. Alexanian, F. Moronta Barrios, G. Demirer, A. Flores, S. Karthikeyan, A. B. Lindner, B. Mackelprang, J. Marken, A. S. Mitra, K. A. Molla, L. Rudenko, M. J. Syberg-Olsen, F. Wu, J. Silberg, C. A. Voigt

An entreaty proposing a non-exhaustive parameter space applicable to diverse organisms for risk assessment based on function rather than origin or development method — arguing that evaluation of impacts (not arbitrary prohibition) is what advances responsible environmental release. Published among the 27 Spirit of Asilomar 2025 outputs.

2025 Co-author

Additional Asilomar 2025 entreaties (co-authored)

Spirit of Asilomar & the Future of Biotechnology Summit · Pacific Grove, CA

Co-authored two further entreaties among the 27 published outputs of the summit. Specific titles, authors, and DOIs available via the Rice Repository collection below.

Workshops, committees & convenings

Standards bodies and policy convenings that produce ongoing outputs.

2025 – Committee member

ASTM International — Committee E62 on Industrial Biotechnology and Synthetic Biology

American Society for Testing and Materials

Active committee member contributing to standardised nomenclature, practices, test methods, and specifications for industrial biotechnology and synthetic biology. Committee E62 outputs (including ASTM E3072 on synthetic-biology terminology) are referenced by U.S. regulators and industry.

2025 Organizing committee

Biotech Beyond Conventional Containment — A Workshop on Policy & Governance

Caltech Linde Center for Science, Society and Policy (LCSSP) · October 6–7, 2025

Two-day Caltech workshop following the Asilomar 2025 summit, focused on policy and governance for biotechnologies that operate outside conventional containment. Yonatan served on the organizing committee alongside Richard Murray, Sara Kassir, and Tom Adamo. Outputs include public-session recordings and forthcoming policy products.

2024 Discussion leader

Pathways Towards the Safe and Effective Deployment of Engineered Microbial Technologies (Caltech LCSSP)

Caltech Linde Center for Science, Society and Policy + Resnick Sustainability Institute · February 2024

Led discussions on the environmental use of genetically modified microorganisms at the Caltech-hosted workshop that fed directly into the LCSSP EMER Report (linked in the Reports section above). Brought together regulators (EPA, USDA), industry (Pivot Bio, ZBiotics, Corteva), and academia.

Forthcoming & ongoing engagements

In-progress and planned policy work, listed for transparency.

2026 → Roadmap

BBCC Clearinghouse — an NGO for Biotechnologies Beyond Conventional Containment

Founding-workshop roadmap · sponsorship under discussion

An independent NGO providing neutral standards, lifecycle stewardship, and registry-based verification for biotechnologies beyond conventional containment. Roadmap drafted; founding workshop, first standards (field-trial protocols, lifecycle reporting, barcoding), and a paper-of-record planned.

2026 → Engagement

NSCEB, GAO and EPA engagement on Asilomar reforms

Per the Asilomar 2025 follow-up plan

Planned engagements with the National Security Commission on Emerging Biotechnology (NSCEB), the U.S. Government Accountability Office (GAO), and EPA leadership to translate the Asilomar 2025 reform package into specific TSCA / FIFRA / SECURE-rule proposals.

Missing something? This page is curated; if you know of a report, panel, or document not listed here that should be, please email us.

See the full CV Publications